Status:
COMPLETED
Clinical, Laboratory and Epidemiologic Pilot Studies of Individuals at High Risk for Viral-Associated Cancers
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
Acquired Immunodeficiency Syndrome
Kaposi's Sarcoma
Eligibility:
All Genders
Up to 65 years
Brief Summary
This protocol presents the rationale, 25-year historical review, and methods for multidisciplinary, low-risk studies of individuals referred to the NCI Viral Epidemiology Branch (VEB). Referrals are g...
Detailed Description
This protocol presents the rationale, 25-year historical review, and methods for multidisciplinary, low-risk studies of individuals referred to the NCI Viral Epidemiology Branch (VEB). Referrals are g...
Eligibility Criteria
- INCLUSION CRITERIA:
Family or personal medical history of neoplasia of an unusual type, pattern, or number.
Known or suspected factor(s) predisposing to neoplasia, such as environmental exposure (particularly immunological or virological), genetic or congenital factors (Mendelian traits predisposing to neoplasia, birth defects, and chromosomal anomalies), or unusual demographic features.
Key Trial Info
Start Date :
December 24 1996
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 31 2011
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT00001560
Start Date
December 24 1996
End Date
October 31 2011
Last Update
July 2 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States, 20892